Literature DB >> 20725542

Topical botulinum toxin.

Ashley Collins, Adnan Nasir.   

Abstract

Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing for increased active ingredient stability, bioavailability, and site-specific targeting. Botulinum toxin has historically been used for the correction of neurological and neuromuscular disorders, such as torticollis, blepharospasm, and strabismus. Recent dermatological indications have been for the management of axillary hyperhydrosis and facial rhytides. Traditional methods of botulinum toxin delivery have been needle-based. These have been associated with increased pain and cost. Newer methods of botulinum toxin formulation have yielded topical preparations that are bioactive in small pilot clinical studies. While there are some risks associated with topical delivery, the refinement and standardization of delivery systems and techniques for the topical administration of botulinum toxin using nanotechnology is anticipated in the near future.

Entities:  

Year:  2010        PMID: 20725542      PMCID: PMC2921740     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  12 in total

1.  One man's poison--clinical applications of botulinum toxin.

Authors:  M Hallett
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

Review 2.  Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.

Authors:  Paul S Yamauchi; Nicholas J Lowe
Journal:  Clin Dermatol       Date:  2004 Jan-Feb       Impact factor: 3.541

Review 3.  Botulinum toxin: mechanisms of action.

Authors:  Dirk Dressler; Fereshte Adib Saberi; Egberto Reis Barbosa
Journal:  Arq Neuropsiquiatr       Date:  2005-04-13       Impact factor: 1.420

Review 4.  Pharmacology of therapeutic botulinum toxin preparations.

Authors:  Dirk Dressler; Reiner Benecke
Journal:  Disabil Rehabil       Date:  2007-12-15       Impact factor: 3.033

5.  Dermatologic toxicity of nanoengineered materials.

Authors:  Adnan Nasir
Journal:  Arch Dermatol       Date:  2008-02

6.  Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.

Authors:  I Chajchir; P Modi; A Chajchir
Journal:  Aesthetic Plast Surg       Date:  2008-05-15       Impact factor: 2.326

7.  Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.

Authors:  Richard G Glogau
Journal:  Dermatol Surg       Date:  2007-01       Impact factor: 3.398

Review 8.  Update on botulinum toxin.

Authors:  Timothy Corcoran Flynn
Journal:  Semin Cutan Med Surg       Date:  2006-09

9.  Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks.

Authors:  Susan K Grimston; Matthew J Silva; Roberto Civitelli
Journal:  Ann N Y Acad Sci       Date:  2007-06-21       Impact factor: 5.691

Review 10.  Botulinal neurotoxins: revival of an old killer.

Authors:  Cesare Montecucco; Jordi Molgó
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

View more
  3 in total

1.  Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.

Authors:  Haley B Naik; Seth M Steinberg; Lindsay A Middelton; Stephen M Hewitt; Rena C Zuo; W Marston Linehan; Heidi H Kong; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

Review 2.  Alternative Methods for Testing Botulinum Toxin: Current Status and Future Perspectives.

Authors:  Mahesh Raj Nepal; Tae Cheon Jeong
Journal:  Biomol Ther (Seoul)       Date:  2020-07-01       Impact factor: 4.634

3.  Use of Botulinum Toxin in Treating Rosacea: A Systematic Review.

Authors:  Hanlin Zhang; Keyun Tang; Yuanzhuo Wang; Rouyu Fang; Qiuning Sun
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.